DOSTIN DOSTIN DOSTIN DOSTIN ERZING ERDOS ERDOS

Dose: 150 to 300 mg
Single Dose: 220 (225)
Frequency: 8 hourly
Route: PO
Instructions:

belongs to Mucoustic. . The Molecular Weight of Erdosteine is 249.31. Its pKa is 3.71.

Erdosteine is contraindicated in conditions like Peptic ulcer,Liver damage,Hepatic cirrhosis with ascites.

The severe or irreversible adverse effects of Erdosteine, which give rise to further complications include LDL high.The signs and symptoms that are produced after the acute overdosage of Erdosteine include Flushing, Sweating, Vertigo.The symptomatic adverse reactions produced by Erdosteine are more or less tolerable and if they become severe, they can be treated symptomatically, these include Headache, Nausea, Urticaria, Erythema, Dermatitis, GIT effects, Taste alteration.

Erdosteine is primarily indicated in conditions like Acute exacerbation of chronic bronchitis, and can also be given in adjunctive therapy as an alternative drug of choice in Respiratory tract disorders.

No data regarding the interactions of Erdosteine was found.

Drug should not be given to patients suffering from Kidney dysfunction, and patients suffering from Liver Malfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

caps Store in a well closed container, Below 20°C. Protect from Sunlight.

'The product in granulates (sachets and suspensions) contains sucrose, keep this into consideration in case of diabetes or low-calorie diets. Safety of erdosteine in pregnancy has not been established and therefore as with all new drugs. Its use is not recommended. Also during lactation its use is not recommended. Keep out from children''s reach. Kidney dysfunction and liver malfunction etc.'